Zdrowie i gospodarka · 10/05/1996

FDA Publishes Draft Guideline on Viral Safety Evaluation of Biotechnology Products Derived From Cell Lines of Human or Animal Origin

The FDA is releasing a draft guideline for evaluating the viral safety of biotechnology products created from cell lines of human or animal origin, developed under the International Conference on Harmonisation, to be submitted in marketing applications.